Premier Alternatives

Tulavi Therapeutics

Los Gatos, CA · Founded 2018 · Privately Held (backing)

Developer of a medical technology platform designed to improve nerve repair and support recovery after nerve injury. Tulavi Therapeutics is based in Los Gatos, CA and was founded in 2018. It was valued at $83 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $34 million across 4 recorded rounds; the latest was a $1 million seed round in Dec 2021.

PMV mark · valuation
$83.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$34.0M
Last round
Seed Round
Dec 2021

Tulavi Therapeutics key facts

as of Oct 2026
  • Developer of a medical technology platform designed to improve nerve repair and support recovery after nerve injury.
  • Tulavi Therapeutics is valued at approximately $83.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $34.0M across 4 recorded rounds; the latest was Seed Round ($1.0M) in Dec 2021.
  • Notable investors include Ascension Ventures, AMED Ventures, Delos Capital Partners, Incept, Iyengar Capital — 6 tracked in total.
  • Tulavi Therapeutics has filed 5 Form Ds with the SEC since 2018, most recently Dec 2021 ($1.0M sold to 9 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$83.0M

Valued at $83.0M at its later-stage round, Jul 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Tulavi Therapeutics with a free account
  • ·Watch Tulavi Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tulavi Therapeutics funding rounds

4 rounds
Dec 2021Seed Round$1.0MSEC filing▮
Feb 2021Early Stage VC$7.5MSEC filing▮
May 2020Seed Round$3.0MSEC filing▮
Apr 2018Seed Round$3.0MSEC filing▮
Full funding history →

Tulavi Therapeutics valuation

Tulavi Therapeutics was valued at $83 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Tulavi Therapeutics raised?

Tulavi Therapeutics has raised $34 million in total; 4 of its rounds are on record, from 2018 on. The largest on record was a $7.5 million early-stage round in Feb 2021; the most recent was a $1 million seed round in Dec 2021.

Tulavi Therapeutics has filed 5 Form Ds with the SEC since 2018, most recently in Dec 2021 ($1 million sold to 9 investors).

Tulavi Therapeutics investors

6 investors are on record for Tulavi Therapeutics, including Ascension Ventures, AMED Ventures, Delos Capital Partners and Incept. The seed round in Dec 2021 drew 9 investors.

About Tulavi Therapeutics

Developer of a medical technology platform designed to improve nerve repair and support recovery after nerve injury. The company offers intuitive nerve repair technologies, enabling surgeons and healthcare providers to treat nerve damage more consistently and support better patient outcomes.

Sector
Healthcare
HQ
Los Gatos, CA, United States
Founded
2018
Employees
31
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.